Inhibition of lipoprotein lipid oxidation.

Handbook of experimental pharmacology

Volumn , Issue 170, 2005, Pages 563-590

  Cynshi, O ^a   Stocker, R ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3-DIHYDRO-5-HYDROXY-2,2-DIPENTYL-4,6-DI-TERT-BUTYLBENZOFURAN; 4,6 DI TERT BUTYL 2,3 DIHYDRO 5 HYDROXY 2,2 DIPENTYLBENZOFURAN; ANTIOXIDANT; BENZOFURAN DERIVATIVE; DRUG DERIVATIVE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; SUCCINOBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; REVIEW;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BENZOFURANS; CARDIOVASCULAR DISEASES; HUMANS; LIPOPROTEINS, LDL; MALONDIALDEHYDE; OXIDATION-REDUCTION; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33645780690     PISSN: 01712004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)